Restatement of Previously Issued Unaudited Interim Condensed Consolidated Financial Statements (Tables)

6 Months Ended

Jun. 30, 2018

Accounting Changes and Error Corrections [Abstract]

Schedule of Error Corrections and Prior Period Adjustments

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (Unaudited)
	Three months ended June 30, 2018										Six months ended June 30, 2018
	As Previously Reported			Adjustments				As Restated			As Previously Reported			Adjustments				As Restated
Revenues:
Revenues, net	$	16,751		$	(502	)	(2), (3)	$	16,249		$	31,296		$	(502	)	(2), (3)	$	30,794
Costs and Expenses:
Cost of revenues	11,728			(263		)	(4)	11,465			21,053			(263		)	(4)	20,790
Selling, general and administrative expenses	5,961			(234		)	(3)	5,727			11,321			(234		)	(3)	11,087
Total costs and expenses	21,656			(497		)		21,159			39,732			(497		)		39,235
Operating loss	(4,905		)	(5		)		(4,910		)	(8,436		)	(5		)		(8,441		)
Other Income (Expense):
Partial extinguishment of Convertible 3.75% Notes	(10,069		)	7,602			(1)	(2,467		)	(10,069		)	7,602			(1)	(2,467		)
Loss before income tax expense	(20,693		)	7,597				(13,096		)	(25,471		)	7,597				(17,874		)
Net loss	$	(20,716	)	$	7,597			$	(13,119	)	$	(25,518	)	$	7,597			$	(17,921	)
Basic and diluted loss per share	$	(0.39	)	$	0.14			$	(0.25	)	$	(0.48	)	$	0.14			$	(0.34	)

CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited)
	June 30, 2018							June 30, 2018
	As Previously Reported			Adjustments				As Restated
Accounts receivable, net	$	16,232		$	(151	)	(2)	$	16,081
Total current assets	49,688			(151		)		49,537
Property, plant and equipment	83,027			263			(4)	83,290
Total assets	$	186,667		$	112			$	186,779
Current liabilities:
Accounts payable	$	8,654		$	117		(2)	$	8,771
Total current liabilities	17,923			117				18,040
Convertible 4.75% Senior Notes, net of debt discount and debt issuance costs (face of $75,090, as of June 30, 2018)	54,963			406			(1)	55,369
Total liabilities	147,544			523				148,067
Additional paid in capital	126,532			(8,008		)	(1)	118,524
Accumulated deficit	(85,612		)	7,597				(78,015		)
Total stockholders’ equity	39,123			(411		)		38,712
Total liabilities and stockholders' equity	$	186,667		$	112			$	186,779

CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS) (Unaudited)
	Three months ended June 30, 2018									Six months ended June 30, 2018
	As Previously Reported			Adjustments			As Restated			As Previously Reported			Adjustments			As Restated
Net loss	$	(20,716	)	$	7,597	(1),(2),(3),(4)	$	(13,119	)	$	(25,518	)	$	7,597	(1),(2),(3),(4)	$	(17,921	)
Comprehensive loss	$	(20,744	)	$	7,597	(1),(2),(3),(4)	$	(13,147	)	$	(25,850	)	$	7,597	(1),(2),(3),(4)	$	(18,253	)

CONDENSED CONSOLIDATED STATEMENT OF STOCKHOLDERS' EQUITY (Unaudited)
	Six months ended June 30, 2018
	As Previously Reported			Adjustments				As Restated
Net loss	$	(25,518	)	$	7,597		(1),(2),(3),(4)	$	(17,921	)
Additional Paid in Capital	126,532			(8,008		)	(1)	118,524
Total Stockholder's Equity	$	39,123		$	(411	)	(1),(2),(3),(4)	$	38,712

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited)
	Six months ended June 30, 2018
	As Previously Reported			Adjustments				As Restated
Cash flows from operating activities:
Net income (loss)	$	(25,518	)	$	7,597		(1),(2),(3),(4)	$	(17,921	)
Stock based compensation	1,113			(10		)	(4)	1,103
Partial extinguishment of Convertible 3.75% Senior Notes	10,069			(7,602		)	(1)	2,467
Changes in operating assets and liabilities:
Accounts receivable	1,023			(5,250		)	(2),(5), (a)	(4,227		)
Accounts payable and accrued expenses	(9,604		)	5,518			(5), (a)	(4,086		)
Net cash provided by operating activities	(12,763		)	253				(12,510		)
Cash flows from investing activities:
Capital expenditures	(12,270		)	(253		)	(4)	(12,523		)
Net cash used in investing activities	(12,270		)	(253		)		(12,523		)
Non cash investing and financing transactions:
Capitalized stock compensation in capital expenditures	53			10			(4)	63

	Condensed Consolidated Statements of Operations
	Three Months Ended June 30, 2017							Six Months Ended June 30, 2017
	As Previously Reported		Adjustments			As Revised		As Previously Reported		Adjustments			As Revised
Revenue, net	$	18,408	$	1,976	(5)	$	16,432	$	38,299	$	4,204	(5)	$	34,095
Cost of revenues	10,371		1,976		(5)	8,395		19,328		4,204		(5)	15,124
Total costs and expenses	20,190		1,976		(5)	18,214		37,114		4,204		(5)	32,910

	Condensed Consolidated Balance Sheet							Condensed Consolidated Balance Sheet
	June 30, 2017							December 31, 2017
	As Previously Reported		Adjustments			As Revised		As Previously Reported		Adjustments			As Revised
Accounts receivable, net	$	27,272	$	2,853	(5),(6)	$	24,419	$	18,143	$	5,401	(5),(6)	$	12,742
Total current assets	95,009		2,853		(5),(6)	92,156		64,532		5,401		(5),(6)	59,131
Total assets	196,385		2,853		(5),(6)	193,532		189,986		5,401		(5),(6)	184,585
Accrued expenses	12,019		2,853		(5),(6)	9,166		13,502		5,401		(5),(6)	8,101
Total current liabilities	21,728		2,853		(5),(6)	18,875		24,097		5,401		(5),(6)	18,696
Total liabilities	137,977		2,853		(5),(6)	135,124		145,233		5,401		(5),(6)	139,832
Total liabilities and stockholders' equity	196,385		2,853		(5),(6)	193,532		189,986		5,401		(5),(6)	184,585

	Condensed Consolidated Statement of Cash Flows
	Six Months Ended June 30, 2017
	As Previously Reported			Adjustments				As Revised
Cash flows from operating activities
Accounts receivable	$	(5,530	)	$	(1,522	)	(5),(6)	$	(4,008	)
Accounts payable and accrued expenses	2,414			1,522			(5),(6)	892

For the three and six months ended June 30, 2018, the Company recorded the following adjustments (in thousands) related to prior periods. The net impact of the adjustments on any prior annual or interim periods financial statements was not significant. There were no adjustments related to prior periods recorded for the three and six months ended June 30, 2017.

	Three months ended			Six months ended
	June 30, 2018			June 30, 2018
Wholesale fees (Revenue)	$	856		$	1,218
Medicaid (Revenue)	297			297
Pricing and shipment adjustment (Revenue) (2), (3)	(502		)	(502		)
Sales return reserve (Revenue)	—			(577		)
Inventory adjustments (Cost of revenues)	—			95
Capitalization of property, plant and equipment (Cost of revenues) (4)	263			263
Bad debt expense (Selling, general and administrative expenses)	(578		)	(578		)
	$	336		$	216